A detailed history of Morgan Stanley transactions in Myomo, Inc. stock. As of the latest transaction made, Morgan Stanley holds 15,910 shares of MYO stock, worth $96,096. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,910
Previous 11,023 44.33%
Holding current value
$96,096
Previous $35,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.81 - $5.63 $13,732 - $27,513
4,887 Added 44.33%
15,910 $63,000
Q1 2024

Aug 16, 2024

SELL
$2.75 - $4.97 $4,647 - $8,399
-1,690 Reduced 13.29%
11,023 $36,000
Q1 2024

May 15, 2024

SELL
$2.75 - $4.97 $4,647 - $8,399
-1,690 Reduced 13.29%
11,023 $36,000
Q4 2023

Aug 16, 2024

BUY
$0.98 - $5.35 $1,656 - $9,041
1,690 Added 15.33%
12,713 $63,000
Q4 2023

Feb 13, 2024

BUY
$0.98 - $5.35 $2,636 - $14,391
2,690 Added 26.84%
12,713 $63,000
Q3 2023

Nov 15, 2023

BUY
$0.55 - $1.31 $5,500 - $13,100
10,000 Added 43478.26%
10,023 $11,000
Q1 2023

May 15, 2023

SELL
$0.4 - $0.77 $5,396 - $10,388
-13,491 Reduced 99.83%
23 $0
Q4 2022

Feb 14, 2023

BUY
$0.44 - $1.6 $5,935 - $21,584
13,490 Added 56208.33%
13,514 $6,000
Q3 2022

Nov 14, 2022

SELL
$1.62 - $2.1 $8 - $10
-5 Reduced 17.24%
24 $0
Q2 2022

Oct 27, 2022

SELL
$1.64 - $4.05 $1,539 - $3,802
-939 Reduced 97.0%
29 $0
Q2 2022

Aug 15, 2022

SELL
$1.64 - $4.05 $1,539 - $3,802
-939 Reduced 97.0%
29 $0
Q1 2022

Oct 27, 2022

BUY
$3.81 - $8.51 $3,577 - $7,990
939 Added 3237.93%
968 $4,000
Q1 2022

May 13, 2022

SELL
$3.81 - $8.51 $47,990 - $107,191
-12,596 Reduced 92.86%
968 $4,000
Q4 2021

Feb 14, 2022

SELL
$6.84 - $14.0 $76,690 - $156,968
-11,212 Reduced 45.25%
13,564 $93,000
Q3 2021

Nov 15, 2021

BUY
$7.53 - $12.69 $186,563 - $314,407
24,776 New
24,776 $295,000

Others Institutions Holding MYO

About MYOMO, INC.


  • Ticker MYO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 7,000,170
  • Market Cap $42.3M
  • Description
  • Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activ...
More about MYO
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.